Archive Newsletter
-
07.05.24 -- Cell & Gene Best Of June
7/5/2024
07/05/24 Cell & Gene Newsletter
-
07.03.24 -- Strategies To Tackle CAR-T Product Challenges
7/3/2024
07/03/24 Cell & Gene Newsletter
-
07.02.24 -- mRNA Delivering Full-length Dystrophin For DMD
7/2/2024
07/02/24 Cell & Gene Newsletter
-
07.01.24 -- Growing Happy Cells: Bioreactor Optimization
7/1/2024
07/01/24 Cell & Gene Newsletter
-
06.27.24 -- Bringing Advanced Therapies To Market
6/27/2024
06/27/24 Cell & Gene Newsletter
-
06.27.24 -- Solid Tumors: Optimized Approaches For Achieving Regulatory Approval
6/27/2024
06/27/24 Cell & Gene Newsletter
-
06.26.24 -- Leveraging CDMO Capabilities To Accelerate CGT Development
6/26/2024
06/26/24 Cell & Gene Newsletter
-
06.26.24 -- What Does FDA's Draft Platform Guidance Mean For CGT Companies?
6/26/2024
06/26/24 Cell & Gene Newsletter
-
06.25.24 -- Novel mAbs? Be Empowered To Innovate
6/25/2024
06/25/24 Cell & Gene Newsletter
-
06.25.24 -- Top Strategies To Reduce Off-Target Effects For Safer Genome Editing
6/25/2024
06/25/24 Cell & Gene Newsletter
This website uses cookies to ensure you get the best experience on our website. Learn more